跳至主要内容
临床试验/NCT00171561
NCT00171561已完成4 期

A 24-week Study to Evaluate the Effectiveness of Valsartan in Combination With Hydrochlorothiazide Versus Amlodipine on Arterial Compliance in Patients With Hypertension, Type 2 Diabetes and Albuminuria

Novartis1 个研究点 分布在 1 个国家目标入组 144 人开始时间: 2003年3月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Novartis
入组人数
144
试验地点
1
主要终点
Blood measures of hypertension after 24 weeks

研究概览

简要总结

The purpose of this study is assess if treatment with valsartan and a diuretic, hydrochlorothiazide, has beneficial effects in people with high blood pressure, diabetes, and albuminuria (protein in the urine) compared with amlodipine. In particular, the study will assess whether the treatment will decrease the stiffness of the blood vessels.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • type 2 diabetes
  • elevated blood pressure and pulse pressure
  • albuminuria

排除标准

  • Severe hypertension
  • History of stroke, myocardial infarction, heart failure, chest pain, abnormal heart rhythm
  • Liver, kidney (not caused by diabetes), or pancreas disease
  • Type 1 diabetes or uncontrolled type 2 diabetes
  • Allergy to certain medications used to treat high blood pressure
  • Other protocol-defined inclusion/exclusion criteria may apply.

结局指标

主要结局

Blood measures of hypertension after 24 weeks

次要结局

  • Blood measures of hypertension in arterial system after 24 weeks
  • Change in protein excretion rate after 24 weeks
  • Change in serum markers of endothelial function and oxidative stress after 24 weeks

研究者

发起方
Novartis
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验